Our meta-analysis demonstrates that the presence of high levels of FOXP3+ TILs is associated with prognosis for breast cancer patients and predicts lymph node metastasis, hormone receptor and HER-2 status. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.